|
顯示項目 346026-346035 / 2348570 (共234857頁)
<< < 34598 34599 34600 34601 34602 34603 34604 34605 34606 34607 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2024-08 |
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): Updated overall survival from a randomised phase 3 study
|
Oh, DY;He, AR;Bouattour, M;Okusaka, T;Qin, S;Chen, LT;Kitano, M;Lee, CK;Kim, JW;Chen, MH;Suksombooncharoen, T;Ikeda, M;Lee, MA;Chen, JS;Potemski, P;Burris, HA, 3rd;Ostwal, V;Tanasanvimon, S;Morizane, C;Zaucha, RE;McNamara, MG;Avallone, A;Cundom, JE;Breder, V;Tan, B;Shimizu, S;Tougeron, D;Evesque, L;Petrova, M;Zhen, DB;Gillmore, R;Gupta, VG;Dayyani, F;Park, JO;Buchschacher, GL, Jr.;Rey, F;Kim, H;Wang, J;Morgan, C;Rokutanda, N;Żotkiewicz, M;Vogel, A;Valle, JW |
| 國家衛生研究院 |
2025-05-15 |
Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study
|
Oh, DY;He, AR;Qin, S;Chen, LT;Okusaka, T;Kim, JW;Suksombooncharoen, T;Lee, MA;Kitano, M;Burris, HA;Bouattour, M;Tanasanvimon, S;Zaucha, R;Avallone, A;Cundom, J;Kuzko, A;Wang, J;Xynos, I;Vogel, A;Valle, JW |
| 國家衛生研究院 |
2025-02 |
Durvalumab, tremelimumab, and platinum chemotherapy in EGFR mutation–positive NSCLC: An open-label Phase 2 trial (ILLUMINATE)
|
Lee, CK;Liao, BC;Subramaniam, S;Chiu, CH;Mersiades, AJ;Ho, CC;Brown, C;Lai, CL;Hughes, BGM;Yang, TY;O'Byrne, K;Luo, YH;Yip, S;Ho, CL;Bray, V;Su, WC;Moore, M;Feng, WL;Bai, YY;Ford, K;Cummins, MM;Stockler, MR;Solomon, BJ;John, T;Chih-Hsin Yang, J |
| 國立臺灣大學 |
1993 |
Dusformone and Dischidiol from Dischida Formosana
|
Chen, Z. S.; Lee, G. H.; 郭悅雄; Chen, Z. S.; Lee, G. H.; Kuo, Yueh-Hsiung |
| 國立成功大學 |
2013-08-27 |
dusfusion 在邊境細胞的功能分析
|
吳榛惟; Wu, Jhen-Wei |
| 國立成功大學 |
2013-07-19 |
dusfusion 在邊境細胞的功能分析
|
吳榛惟; Wu, Jhen-Wei |
| 國立臺灣大學 |
2015 |
DUSP1 Expression Induced by HDAC1 Inhibition Mediates Gefitinib Sensitivity in Non-Small Cell Lung Cancers
|
Lin, Yun-Chieh; Lin, Yu-Chin; Shih, Jin-Yuan; Huang, Wei-Jan; Chao, Shi-Wei; Chang, Yih-Leong; Chen, Ching-Chow; 張逸良; 施金元; 陳青周 |
| 臺大學術典藏 |
2018-09-10T15:17:53Z |
DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers
|
Lin, Yun-Chieh;Lin, Yu-Chin;Shih, Jin-Yuan;Huang, Wei-Jan;Chao, Shi-Wei;Chang, Yih-Leong;Chen, Ching-Chow; Lin, Y.-C. and Lin, Y.-C. and Shih, J.-Y. and Huang, W.-J. and Chao, S.-W. and Chang, Y.-L. and Chen, C.-C.; 張逸良;施金元;陳青周; YIH-LEONG CHANG; Lin, Yun-Chieh; JIN-YUAN SHIH; Lin, Yu-Chin; Shih, Jin-Yuan; Huang, Wei-Jan; Chao, Shi-Wei; Chang, Yih-Leong; Chen, Ching-Chow |
| 臺大學術典藏 |
2020-03-07T06:56:23Z |
DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers
|
Lin Y.-C.;Lin Y.-C.;Shih J.-Y.;Huang W.-J.;Chao S.-W.;Yih-Leong Chang;Chen C.-C.; Lin Y.-C.; Lin Y.-C.; Shih J.-Y.; Huang W.-J.; Chao S.-W.; YIH-LEONG CHANG; Chen C.-C. |
| 臺大學術典藏 |
2021-05-07T05:13:26Z |
DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers
|
Lin Y.-C.; Lin Y.-C.; Shih J.-Y.; Huang W.-J.; Chao S.-W.; Chang Y.-L.; CHING-CHOW CHEN |
顯示項目 346026-346035 / 2348570 (共234857頁)
<< < 34598 34599 34600 34601 34602 34603 34604 34605 34606 34607 > >>
每頁顯示[10|25|50]項目
|
